Atovaquone‐Statine “Double‐Drugs” with High Antiplasmodial Activity

• DOI: 10.1002/cmdc.200700166
• Publication Date: 2007-12-06T20:18:58Z
• Authors: Sergio Romeo; Silvia Parapini; Mario Dell'Agli; Nadia Vaiana; Pietro Magrone; Germana Galli; Anna Sparatore; Donatella Taramelli; Enrica Bosisio
• Keywords: Atovaquone; Unavailability; Drug Development; New drug application

Combining chemicals. Malaria is one of the most widespread parasitic infections in world, however, unavailability a vaccine and spread intensification drug resistance over past 15–20 years have led to dramatic decline efficacy affordable antimalarial drugs. Herein, development “double-drugs” tackle inhibition P. falciparum growth discussed. Supporting information for this article available on WWW under http://www.wiley-vch.de/contents/jc_2452/2008/z700166_s.pdf or from author. Please note: The publisher not responsible content functionality any supporting supplied by authors. Any queries (other than missing content) should be directed corresponding author article.